Event Calendar
Prev MonthPrev Month Next MonthNext Month
Single-Session Dance Therapy and Schizophrenia: Theory, Practice, and Research Webinar
Monday, May 24, 2021
Category: Webinar


The brevity of psychiatric inpatient treatment was originally intended to decrease institutionalization of patients receiving services, some of whom spent decades tucked away in psychiatric facilities with limited treatment. However, current inpatient psychiatric hospitalizations are lasting as few as 3 days, with a typical length of stay being approximately ten days. Patients experiencing acute symptoms of schizophrenia often come into psychiatric hospitals and merely receive psychopharmacological treatment to help manage positive symptomatology including auditory and visual hallucinations, delusional thinking, and paranoia.
Although psychopharmacological interventions may support stabilization for the positive symptoms of schizophrenia, they have not been proven effective for negative symptoms including flat affect, isolation, decreased spontaneity and self-expression, and diminished interpersonal skills. Additionally, the medication non-adherence rate of people with schizophrenia is quite high, which calls for psychosocial treatment options. Taking into account short lengths of stay coupled with medication non-adherence, it is clear that we must re-evaluate effective treatment options for this vulnerable population. Single-session therapy has been implemented primarily in outpatient settings with little research suggesting its use inpatient. Single-session DMT could bridge the connection between psychopharmacological and psychosocial treatment interventions for this underserved population.
In this workshop, we will look at the theory behind single-session therapy using dance/movement therapy as the intervention including: consideration on how to structure a single DMT session, significant goals to address in a single-session intervention, and DMT treatment interventions to meet the needs of the participants in only one therapy session. A focus will be placed on stabilization through grounding, ego-strengthening, and interpersonal skill development. Clinically, I will share examples of conducting single-session DMT interventions with people diagnosed with schizophrenia in an inpatient psychiatric facility. Case studies will highlight patient experiences through the research process, overarching themes in the single DMT sessions, and particular treatment goals targeted. Finally, having completed research to determine the feasibility and effectiveness of single session DMT interventions, I will review quantitative results from pre- and post-intervention test scores, as well as often unheard personal experiences of the participant from qualitative interviews conducted post sessions.

Learning Objectives:
1. Participants will recognize the specific psychosocial treatment needs of individuals with schizophrenia as they relate to symptomatology as well as hospitalization.
2. Participants will be able to illustrate the parameters, structure, and benefit of a Single-Session Therapy Intervention.
3. Participants will appraise the benefits and research results of facilitating Single-Session DMT interventions both quantitatively and qualitatively through the experience of participants who have engaged in a Single-Session DMT intervention. 

Continuing Education: 1.5 ADTA, NBCC, NY LCAT CEs

Jacelyn Biondo, Ph.D., BC-DMT, LPC loves exploring the psyche/soma connection, the relationship between dance/movement therapy and schizophrenia, the concept of seeing and being seen, and the role of community within each of these areas. Her research, clinical work, and life experiences have piqued her interest in the concepts of community, intimacy, and belonging particularly as they relate to communities which are often underrepresented and dehumanized.  Dr. Biondo completed a Postdoctoral Research Fellowship in Creative Arts Therapies at Drexel University. She sits on the National Board of the American Dance Therapy association as Treasurer and Executive Committee Member and on the Pennsylvania Chapter of the ADTA as President. Dr. Biondo graduated with her Bachelor of Fine Arts from California Institute of the Arts with a dual major in dance and photography, her Master of Arts from Drexel University in Dance/Movement Therapy, and her PhD in Creative Arts in Therapy at Drexel University. Dr. Biondo is an adjunct faculty member at Drexel University, Pratt Institute, and Lesley University and has guest lectured nationally and internationally on dance therapy and schizophrenia, de-escalation and violence prevention, artistic inquiry, and arts-based research. She joins a team of colleagues in the Global Arts-Based Research Consortium, bringing awareness to and conducting Arts-Based Research. Her future will most certainly include dancing with people with schizophrenia, conducting research, traveling, learning, eating delicious food, and advocating for art, arts therapies, equality, and a kinder humanity. 


  • ADTA Member $35
  • Non-Member $45
  • Student $15 

Can’t attend the webinar live? This webinar will be added to the ADTA CE Center Catalog 2-3 weeks after each recording and will be available for On-Demand purchase then. 

Please note: Registrants will receive an email prior to each webinar purchased, outlining all access instructions. Please make sure you check your spam/junk folder if you do not receive this email. Registrants having difficulty can contact the ADTA office at 518-704-3636 or [email protected]. Office hours are 9:00 AM EST - 4:30 PM EST. 
The American Dance Therapy Association has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5739. Programs that do not qualify for NBCC credit are clearly identified. The American Dance Therapy Association is solely responsible for all aspects of the programs.
The American Dance Therapy Association is recognized by the New York State Education Department’s State Board for Mental Health Practitioners as an approved provider of continuing education for Licensed Creative Arts Therapists #CAT-0035.